Photodynamic therapy with Verteporfin in subfoveal choroidal metastasis of breast carcinoma (a controlled case).
A 55-year old woman with growing unilateral subfoveal choroidal metastasis of breast carcinoma was treated by photodynamic therapy (PDT) with verteporfin. Best corrected visual acuity remained stable during the whole follow-up of 6 months. Tumor flattened from 2.2 mm to 0 mm on ultrasound one month after the therapy. PDT with verteporfin appears to be the best tolerated method for palliative treatment of growing subfoveal choroidal metastasis of the breast carcinoma.
Soucek
Petr
P
The Eye Department, University Hospital Kralovske Vinohrady, Prague, Czech Republic. soucek@fnkv.cz
Cihelkova
Ilona
I
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018276:Carcinoma, Medullary / Q000188:drug therapy* / Q000556:secondary; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D006801:Humans; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods*; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D016896:Treatment Outcome; D000077362:Verteporfin; D014792:Visual Acuity
D000970:Antineoplastic Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin